» Articles » PMID: 26947005

Defining the Polyposis/colorectal Cancer Phenotype Associated with the Ashkenazi GREM1 Duplication: Counselling and Management Recommendations

Overview
Specialty Genetics
Date 2016 Mar 8
PMID 26947005
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Hereditary mixed polyposis is a genetically heterogeneous, autosomal dominant condition with adenomatous, hyperplastic and juvenile polyps. We conducted a comprehensive clinical evaluation of a large Ashkenazi Jewish family with this phenotype and performed extensive genetic testing. As seen in one previous report, a 40 kb duplication upstream of GREM1 segregated with the polyposis/colon cancer phenotype in this kindred. Our study confirms the association of GREM1 with mixed polyposis and further defines the phenotype seen with this mutation. This gene should be included in the test panel for all Jewish patients with mixed polyposis and may be considered in any Ashkenazi patient with unexplained hereditary colon cancer when mutations in other hereditary colon cancer genes have been ruled out.

Citing Articles

How many is too many? Polyposis syndromes and what to do next.

Gupta N, Drogan C, Kupfer S Curr Opin Gastroenterol. 2021; 38(1):39-47.

PMID: 34839308 PMC: 8648991. DOI: 10.1097/MOG.0000000000000796.


Genetic risk factors for colorectal cancer in multiethnic Indonesians.

Yusuf I, Pardamean B, Baurley J, Budiarto A, Miskad U, Lusikooy R Sci Rep. 2021; 11(1):9988.

PMID: 33976257 PMC: 8113452. DOI: 10.1038/s41598-021-88805-4.


Identification of a novel GREM1 duplication in a patient with multiple colon polyps.

McKenna D, van den Akker J, Zhou A, Ryan L, Leon A, OConnor R Fam Cancer. 2018; 18(1):63-66.

PMID: 29804199 PMC: 6261785. DOI: 10.1007/s10689-018-0090-6.

References
1.
Cheah P, Wong Y, Chau Y, Loi C, Lim K, Lim J . Germline bone morphogenesis protein receptor 1A mutation causes colorectal tumorigenesis in hereditary mixed polyposis syndrome. Am J Gastroenterol. 2009; 104(12):3027-33. DOI: 10.1038/ajg.2009.542. View

2.
Boparai K, Dekker E, van Eeden S, Polak M, Bartelsman J, Mathus-Vliegen E . Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis. Gastroenterology. 2008; 135(6):2014-8. DOI: 10.1053/j.gastro.2008.09.020. View

3.
Lindor N . Familial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndrome. Surg Oncol Clin N Am. 2009; 18(4):637-45. PMC: 3454516. DOI: 10.1016/j.soc.2009.07.003. View

4.
Jaeger E, Leedham S, Lewis A, Segditsas S, Becker M, Cuadrado P . Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1. Nat Genet. 2012; 44(6):699-703. PMC: 4594751. DOI: 10.1038/ng.2263. View

5.
Patel S, Ahnen D . Familial colon cancer syndromes: an update of a rapidly evolving field. Curr Gastroenterol Rep. 2012; 14(5):428-38. PMC: 3448005. DOI: 10.1007/s11894-012-0280-6. View